Showing 1421-1430 of 1635 results for "".
- Prevent Blindness and Bausch + Lomb to Launch Year-Long Video Series to Raise Awareness of Wet AMDhttps://modernod.com/news/prevent-blindness-and-bausch-lomb-to-launch-year-long-video-series-to-raise-awareness-of-wet-amd/2478818/Bausch + Lomb and Prevent Blindness, the nation’s oldest volunteer eye health non-profit organization, announced they are joining together for the sixth consecutive year during AMD Awareness Month to raise awareness of age-related macular degeneration (AMD). The two organizations will launch a ye
- Researchers Use Patients’ Cells to Test Gene Therapy for a Form of Leber Congenital Amauroshttps://modernod.com/news/researchers-use-patients-cells-to-test-gene-therapy-for-a-form-of-leber-congenital-amauros/2478810/Scientists at the National Eye Institute (NEI) have developed a promising gene therapy strategy for a rare disease that causes severe vision loss in childhood. A form of Leber congenital amaurosis, the disease is caused by autosomal-dominant mutations in the CRX gene, which are ch
- Merck Shuts Down Covid Vaccine Program After Lackluster Datahttps://modernod.com/news/merck-shuts-down-covid-vaccine-program-after-lackluster-data/2478791/Merck is discontinuing development of its two experimental Covid-19 vaccines after early trial data showed they failed to generate immune responses comparable to a natural infection or existing vaccines, according to a Bloomberg
- Biden Picks Former FDA Commissioner David Kessler to Lead Operation Warp Speedhttps://modernod.com/news/biden-picks-former-fda-commissioner-david-kessler-to-lead-operation-warp-speed/2478768/US President-elect Joe Biden announced a number of appointments to the incoming team handling the response to the COVID-19 pandemic, including naming David Kessler as chief science officer. Mr. Kessler, who served as FDA commissioner between 1990 and 1997, will reportedly share oversight of Opera
- Avellino Exceeds 1 Million COVID-19 Tests in 2020 and Welcomes New Executive Team Hires In 2021https://modernod.com/news/avellino-exceeds-1-million-covid-19-tests-in-2020-and-welcomes-new-executive-team-hires-in-2021/2478756/Avellino Lab USA announced that the company performed over 1 million AvellinoCoV2 COVID-19 tests since March 2020, and has further expanded the company’s executive team to drive additional development and commercial growth in 2021. Chief Scientific Officer, Nazneen Aziz, PhD, and Global Head of S
- JPM: BioNTech Hikes COVID-19 Vaccine Output to 2B Doses in 2021—And Plans a Bigger Label, Toohttps://modernod.com/news/jpm-biontech-hikes-covid-19-vaccine-output-to-2b-doses-in-2021-and-plans-a-bigger-label-too/2478746/With its Pfizer-partnered COVID-19 vaccine authorized in the U.S., Europe, the U.K. and a slate of other countries, German mRNA specialist BioNTech is wasting no time scaling up its 2021 pandemic ambitions—namely, 2 billion shots by year-end, plus a slate of new approvals and a temperature-stable
- Aviceda Therapeutics Announces Formation of Executive Teamhttps://modernod.com/news/aviceda-therapeutics-announces-formation-of-executive-team/2478745/Aviceda Therapeutics has announced the composition of the Executive Team that will guide the company through ongoing development of first-in-class therapeutics and continued growth opportunities as a business entity. Aviceda’s lead ophthalmic optimized nanoparticle, as an intravitreal form
- Kala Pharmaceuticals Announces Commercial Availability of Eysuvis for the Treatment of Dry Eye Diseasehttps://modernod.com/news/kala-pharmaceuticals-announces-commercial-availability-of-eysuvis-for-the-treatment-of-dry-eye-disease/2478729/Kala Pharmaceuticals announced the launch of Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to 2 weeks) treatment of the signs and symptoms of dry eye disease. Eysuvis is now available in national and
- EyeCare Associates of East Texas Announces Partnership With Private Equity Firm EyeCare Partnershttps://modernod.com/news/eyecare-associates-of-east-texas-announces-partnership-with-private-equity-firm-eyecare-partners/2478721/Brown Gibbons Lang & Company (BGL) has announced a new partnership between EyeCare Associates of East Texas (ECA) and EyeCare Partners (ECP) resulting in the addition of ECA’s four Texas clinics to ECP’s national ne
- Fewer New Cases of Intraocular Inflammation After First Year of Abicipar in AMD Patientshttps://modernod.com/news/fewer-new-cases-of-intraocular-inflammation-after-first-year-of-abicipar-in-amd-patients/2478703/Most cases of intraocular inflammation in patients with neovascular age-related macular degeneration (nAMD) who take AbbVie’s investigational drug abicipar pegol develop during the first year of treatment, according to a new report of two-year efficacy and safety results from a couple of pi